首页> 外文期刊>Journal of minimal access surgery >Surgical outcome of laparoscopic hepatic resection for hepatocellular carcinoma: A matched case–control study with propensity score matching
【24h】

Surgical outcome of laparoscopic hepatic resection for hepatocellular carcinoma: A matched case–control study with propensity score matching

机译:腹腔镜肝切除术治疗肝细胞癌的手术结局:倾向评分匹配的病例对照研究

获取原文
获取外文期刊封面目录资料

摘要

Background: Although the number of reports on laparoscopic hepatic resection (LHR) has increased, studies of long-term outcomes regarding tumor recurrence and patient survival compared to the conventional open approach are limited. We evaluated the long-term survival and feasibility of LHR in patients with hepatocellular carcinoma (HCC). Patients and Methods: A retrospective analysis was performed on the clinical data of patients who underwent hepatic resection for primary HCC between August 2000 and December 2013. The patients were divided into the LHR or open hepatic resection (OHR) groups. To control for selection bias in the two groups, propensity score matching was used at a 1:1 ratio based on the following covariates: Child–Pugh grade, tumour size, tumour number and tumour location. Following propensity score matching, thirty patients were included in the LHR group and thirty were included in the OHR group. Results: The respective disease-free survival rates at 1 year, 3 years and 5 years were 78.4%, 61.1% and 38.9%, respectively, for the LHR group, and 89.3%, 57.5% and 47.9%, respectively, for the OHR group (P = 0.89). Also, the overall survival rates at 1 year, 3 years and 5 years were 96.4%, 68.2% and 62.5%, respectively, for the LHR group and 100.0%, 95.8% and 72.3%, respectively, for the OHR group (P = 0.44). Conclusions: According to our study, using propensity score matching, LHR for HCC is safe, feasible and comparative, with good oncologic results.
机译:背景:尽管有关腹腔镜肝切除术(LHR)的报道数量有所增加,但与传统的开放治疗相比,有关肿瘤复发和患者生存率的长期结果的研究有限。我们评估了LHR在肝细胞癌(HCC)患者中的长期存活率和可行性。患者与方法:对2000年8月至2013年12月接受原发性肝癌肝切除术的患者的临床资料进行回顾性分析。将患者分为LHR组或开放性肝切除(OHR)组。为了控制两组的选择偏倚,根据以下协变量以1:1的比例使用倾向得分匹配:Child–Pugh分级,肿瘤大小,肿瘤数目和肿瘤位置。倾向得分匹配后,LHR组包括30例患者,OHR组包括30例。结果:LHR组分别在1年,3年和5年的无病生存率分别为78.4%,61.1%和38.9%,而OHR分别为89.3%,57.5%和47.9%组(P = 0.89)。此外,LHR组在1年,3年和5年时的总生存率分别为96.4%,68.2%和62.5%,而OHR组分别为100.0%,95.8%和72.3%(P = 0.44)。结论:根据我们的研究,使用倾向评分匹配,LHR用于HCC是安全,可行和可比较的,并具有良好的肿瘤学结果。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号